Inventor · disambiguated record
Aleem Fazal
Also filed as: FAZAL ALEEM
7 granted patents·4 pending applications·100 citations·filing 2013–2022
86Inventor score
Top patents by PatentIndex Score
11 records- 0196US10414755B23-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2018·Granted Sep 17, 2019·18 cites·25 claims
- 0295US11053218B23-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2020·Granted Jul 6, 2021·4 cites·21 claims
- 0394US10195196B21,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditionsNOVARTIS AG·Filed 2016·Granted Feb 5, 2019·15 cites·9 claims
- 0494US8729263B21,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditionsCHEUNG ATWOOD KIM·Filed 2013·Granted May 20, 2014·45 cites·5 claims
- 0591US9545404B21,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditionsNOVARTIS AG·Filed 2014·Granted Jan 17, 2017·16 cites·10 claims
- 0687US10758533B21,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditionsNOVARTIS AG·Filed 2019·Granted Sep 1, 2020·2 cites·8 claims
- 0777US2022387428A11,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditionsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0873US2021309638A13-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0972US11229648B21,4-disubstituted pyridazine analogs thereof and methods for treating SMN-deficiency-related conditionsNOVARTIS AG·Filed 2020·Granted Jan 25, 2022·0 cites·24 claims
- 1056US2025276964A1Benzisoxazole Derivatives and Uses thereofNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1149US2022363671A1Glue degraders and methods of use thereofNOVARTIS AG·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aleem Fazal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →